John Y. Kao

THE CONDUCT OF IN VITRO AND IN VIVO DRUG-DRUG INTERACTION STUDIES: A PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA) PERSPECTIVE

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · Drug Metabolism and Disposition · 2003 · 784 citations

Medicine, Pharmacokinetics, Pharmacology +17

Fecal Microbiota Transplant for Treatment of Clostridium difficile Infection in Immunocompromised Patients

Colleen Kelly, Chioma Ihunnah, Monika Fischer et al. · The American Journal of Gastroenterology · 2014 · 640 citations · Full text

Life Sciences, Infectious Diseases, Internal Medicine +7

Helicobacter pylori Immune Escape Is Mediated by Dendritic Cell–Induced Treg Skewing and Th17 Suppression in Mice

John Y. Kao, Min Zhang, Mark J. Miller et al. · Gastroenterology · 2009 · 319 citations

Life Sciences, Immunology, Infectious Diseases +14

The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective

Thorir D. Bjornsson, John T. Callaghan, Heidi J. Einolf et al. · The Journal of Clinical Pharmacology · 2003 · 309 citations

Medicine, Pharmacokinetics, Pharmacology +17

Candida albicans and Bacterial Microbiota Interactions in the Cecum during Recolonization following Broad-Spectrum Antibiotic Therapy

Katie L. Mason, John R. Erb‐Downward, Kelly D. Mason et al. · Infection and Immunity · 2012 · 277 citations · Full text

Life Sciences, Microbiology, Pharmacology +17